Bangkok Lab And Cosmetic PCL (BKK: BLC)

Market Cap	2.57B
Revenue (ttm)	1.55B
Net Income (ttm)	166.85M
Shares Out	600.00M
EPS (ttm)	0.28
PE Ratio	15.39
Forward PE	n/a
Dividend	0.13 (3.04%)
Ex-Dividend Date	Aug 27, 2024

Volume	1,125,200
Average Volume	1,543,756
Open	4.260
Previous Close	4.280
Day's Range	4.240 - 4.360
52-Week Range	4.080 - 6.300
Beta	n/a
RSI	45.22
Earnings Date	Feb 28, 2025

About BKK: BLC

Bangkok Lab And Cosmetic Public Company Limited manufacturing and distributing of pharmaceuticals and medicinal chemical products for humans and animals in Thailand, Laos, Cambodia, Hongkong, Vietnam, and internationally. The company distributes food supplements, cosmeceuticals, and pharmaceutical drugs; medicine, medical supplies, tonics, and supplements for animals; and supplementary food and herbs. It also engages in provision of management consulting and logistic services; and export of cosmeceuticals, pharmaceutical drugs, medicines, herbs...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2022
• Employees: 947
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: BLC

Financial Performance

In 2023, BLC's revenue was 1.42 billion, an increase of 14.11% compared to the previous year's 1.24 billion. Earnings were 145.39 million, an increase of 15.65%.